Harnessing the Power of Nature’s Immune System

Nature’s way to fight disease via our DiversImmune platform

Preclinical Product Development

At Abpro, we offer a full range of in vivo preclinical early stage research, efficacy, pharmacology, and safety studies. With our expertise and experience, we can offer a wide range of standard study designs in pharmacology, toxicology, cancer xenograft, metabolic, and immunology models. Our hands-on collaborative approach with our clients means that our scientists will work with you to learn your specific preclinical study requirements and assist you from initial study design to final reporting of your data to provide you with dependable results.


Metabolic Disease Models

Choosing the most appropriate model for your metabolic disease research and drug development projects is crucial for proper efficacy assessment of therapeutic interventions. At Abpro, we can work...

Learn More →

Cancer Disease Models

Whether you are assessing small molecule drug candidate efficacy in a human xenograft tumor mouse model, or evaluation of immune-based therapies in a syngeneic mouse tumor model, Abpro provides...

Learn More →

Inflammation and Autoimmune Models

With the wide range of rodent autoimmune and inflammatory models of human disease it can be confusing to decide which model is best for your particular drug development and research needs. Our...

Learn More →

Pharmacology Services

Abpro offers in vivo preclinical pharmacology services in both mouse and rat using a full range of dosing administration routes and regimens for both small molecules and biologics. Tissue and body...

Learn More →

Toxicology Services

Abpro offers a full range of in vivo non-GLP toxicology services in both mice and rats providing early assessment of drug candidate toxicity allowing for a more informed drug discovery direction...

Learn More →

Receive updates from Abpro

Contact us →